Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q1 2018 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size. The question asks: does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that reported results look like early portion of something meaningfully bigger? Answer YES if management's own words convey that the company is small and what is happening now is disproportionately large compared with that smallness. We need to look for statements about current business being large relative to company size. For example, a single contract or customer that could rival or exceed meaningful share of today's company. Or that the company is handling volumes that would have been out of reach until now. Or that same absolute wins translate into outsized percentage change because base is small. In the transcript, management discusses results, backlog, guidance. They mention that Q1 revenues increased 57% year-over-year, EBITDA up 89% year-over-year. That is growth, but is that conveying disproportion? They also mention that they have a $1.5 billion backlog, with $426 million scheduled for 2018. That is large relative to revenue? Revenue for 2017 was around? Let's see: Q1 2018 revenue $164 million, so annualized ~$656 million. Backlog $1.5 billion is about 2.3 times annual revenue. That might be significant, but is management conveying that the company is small relative to what is arriving? They don't explicitly say "we are small" or "this is disproportionately large." They talk about strong backlog, but that's normal for this industry. They also mention the Q7000, which is a new vessel expected to be ready in 2019. They talk about opportunities in West Africa, Brazil, etc. But that is prospective, not current. They mention that they are trending towards upper half of guidance. That's just guidance. They mention that they have better visibility on backlog in Canyon this year. But again, not about disproportion. The question specifically asks: "does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is?" We need to see if management explicitly or implicitly conveys that the company is small and what is happening is large relative to that.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.